Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

STAMP-I protocol × 30 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 1 Agnosia 1

Interventions

Specimen Handling 367 Magnetic Resonance Spectroscopy 298 pembrolizumab 292 Biopsy 231 Carboplatin 207 Cyclophosphamide 185 Cisplatin 168 Paclitaxel 156 Nivolumab 139 Gemcitabine 131 Radiotherapy 121 venetoclax 116 Bevacizumab 110 Dexamethasone 102 fludarabine 92 Pemetrexed 88 Rituximab 87 Fluorouracil 86 Oxaliplatin 85 Doxorubicin 84 durvalumab 83 Docetaxel 80 atezolizumab 78 Prednisone 76 Radiation 73 Lenalidomide 72 X-Rays 66 Ipilimumab 66 Leucovorin 64 Capecitabine 64

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06117709 2026-03-19

Integrated Smartphone Technology to Alleviate Malignant Pain (I-STAMP) Testing

Dana-Farber Cancer Institute

Phase NA Not yet recruiting

Agnosia, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡